GENOTONORM Side Effects

6939968-8 | Melanocytic Naevus
on Aug 13, 2010 Male patient from CHILE , 14 years of age, was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: melanocytic naevus. Genotonorm dosage: .

6916264-6 | Alopecia, Anaemia, Haematocrit Decreased
Patient was taking Genotonorm (View Usage). Patient had the following side effects: alopecia, anaemia, haematocrit decreased on Jul 29, 2010 from FRANCE Additional patient health information: Female patient , child 12 years of age, weighting 83.78 lb, was diagnosed with growth hormone deficiency, asthma (What is asthma?) and. Genotonorm dosage: 1.9 Mg, Cyclic. During the same period patient was treated with SERETIDE (Unk) (View Seretide Review and Seretide Label ), SINGULAIR (5 Mg, 1x/day) (View Singulair Review and Singulair Label ), CEFPODOXIME (200 Mg In 2 Intakes) (View Cefpodoxime Review and Cefpodoxime Label ), CETIRIZINE (10 Mg, 1x/day) (View Cetirizine Review and Cetirizine Label ).

6839605-7 | Ependymoma, Headache, Vomiting
Adverse event was reported on Jul 07, 2010 by a Male patient taking Genotonorm (View Usage) (Dosage: 1.2 Mg, 1x/day) was diagnosed with growth hormone deficiency and. Location: SPAIN , 13 years of age, After Genotonorm was administered, patient had the following side effects: ependymoma, headache (What is headache?), vomiting. Patient was hospitalized.

6817727-4 | Haematological Malignancy
on Jun 29, 2010 Male patient from FRANCE , child 10 years of age, was diagnosed with growth hormone deficiency and was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: haematological malignancy. Genotonorm dosage: 1 Mg, 1x/day. Patient was hospitalized.


6703848-3 | Attention Deficit/hyperactivity Disorder
on Apr 20, 2010 Female patient from SPAIN , child 12 years of age, was diagnosed with turner's syndrome and was treated with Genotonorm (View Usage). Patient had the following side effects: attention deficit/hyperactivity disorder. Genotonorm dosage: 1.4 Mg, 1x/day.

6520352-6 | Chronic Myeloid Leukaemia
Patient was taking Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: chronic myeloid leukaemia on Dec 14, 2009 from SPAIN Additional patient health information: Female patient , 51 years of age, was diagnosed with growth hormone deficiency, hypopituitarism and. Genotonorm dosage: 0.2 Mg, For 5 Days Of Week. During the same period patient was treated with IRON (Unk) (View Iron Review and Iron Label ), MAGNESIUM (Unk, As Needed) (View Magnesium Review and Magnesium Label ), HIDROALTESONA (Unk) (View Hidroaltesona Review and Hidroaltesona Label ), HIDROFEROL (20 Ml, Unk) (View Hidroferol Review and Hidroferol Label ), LEVOTHROID (50 Ug, Unk) (View Levothroid Review and Levothroid Label ).

6484677-5 | Medulloblastoma Recurrent
Adverse event was reported on Nov 27, 2009 by a Male patient taking Genotonorm (View Usage) (Dosage: 0.5 Mg, 1x/day) . Location: FRANCE , child 9 years of age, Patient experienced the following unwanted or unexpected effects: medulloblastoma recurrent. During the same period patient was treated with LEVOTHYROXINE SODIUM (25 Ug, 1x/day) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6474533-0 | Medulloblastoma Recurrent
on Nov 26, 2009 Male patient from FRANCE , child 11 years of age, weighting 63.93 lb, was diagnosed with growth hormone deficiency and was treated with Genotonorm (View Usage). Patient had the following side effects: medulloblastoma recurrent. Genotonorm dosage: 0.9 Mg, 1x/day.

6402191-X | Dermoid Cyst, Metastatic Neoplasm, Neuroendocrine Tumour
on Oct 01, 2009 Female patient from FRANCE , 50 years of age, was diagnosed with growth hormone deficiency, hypopituitarism and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: dermoid cyst, metastatic neoplasm, neuroendocrine tumour. Genotonorm dosage: 0.5 Mg, 1x/day.

6398368-2 | Acromegaly
Patient was taking Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: acromegaly on Oct 05, 2009 from SPAIN Additional patient health information: Female patient , 13 years of age, . Genotonorm dosage: 1.2 Mg, 1x/day.

6338016-0 | Acromegaly
Adverse event was reported on Aug 21, 2009 by a Female patient taking Genotonorm (View Usage) (Dosage: 1.2 Mg, 1x/day) . Location: SPAIN , 13 years of age, Patient had the following side effects: acromegaly.

5950902-X | Colon Cancer Metastatic
on Nov 04, 2008 Male patient from FRANCE , weighting 227.1 lb, was diagnosed with hypopituitarism and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: colon cancer metastatic. Genotonorm dosage: Daily Dose:.3mg-freq:daily. During the same period patient was treated with LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), TOCO (View Toco Review and Toco Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), URSOLVAN 200 (View Ursolvan-200 Review and Ursolvan-200 Label ), APROVEL (View Aprovel Review and Aprovel Label ), EZETROL (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

5928446-0 | Muscle Disorder, Muscle Enzyme Increased
on Oct 13, 2008 Male patient from FRANCE , child 6 years of age, was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: muscle disorder (What is muscle disorder?), muscle enzyme increased. Genotonorm dosage: .

5919844-X | Lymphoma
Patient was taking Genotonorm (View Usage). Patient had the following side effects: lymphoma (What is lymphoma?) on Oct 06, 2008 from FRANCE Additional patient health information: Male patient , 50 years of age, was diagnosed with hypopituitarism and. Genotonorm dosage: . During the same period patient was treated with PITUITARY AND HYPOTHALAMIC HORMONES (View Pituitary And Hypothalamic Hormones Review and Pituitary And Hypothalamic Hormones Label ).

5885264-X | Myelodysplastic Syndrome
Adverse event was reported on Sep 09, 2008 by a Female patient taking Genotonorm (View Usage) (Dosage: ) was diagnosed with growth retardation, hypogonadism female and. Location: FRANCE , weighting 66.14 lb, After Genotonorm was administered, patient had the following side effects: myelodysplastic syndrome. During the same period patient was treated with MAXOMAT (View Maxomat Review and Maxomat Label ), ESTRADIOL HEMIHYDRATE (View Estradiol Hemihydrate Review and Estradiol Hemihydrate Label ).

5856848-X | Headache, Loss Of Consciousness
on Aug 13, 2008 Male patient from BELGIUM , child 11 years of age, was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), loss of consciousness. Genotonorm dosage: .

5810465-6 | Metastases To Lung, Metastasis
on Jul 04, 2008 Female patient from FRANCE , weighting 101.4 lb, was diagnosed with growth hormone deficiency and was treated with Genotonorm (View Usage). Patient had the following side effects: metastases to lung, metastasis. Genotonorm dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5760319-9 | Colon Cancer Metastatic
Patient was taking Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: colon cancer metastatic on May 21, 2008 from FRANCE Additional patient health information: Male patient , weighting 227.1 lb, was diagnosed with hypopituitarism and. Genotonorm dosage: Daily Dose:.3mg-freq:daily. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), TOCO (View Toco Review and Toco Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), URSOLVAN 200 (View Ursolvan-200 Review and Ursolvan-200 Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), EZETROL (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

5751281-3 | Medulloblastoma Recurrent
Adverse event was reported on May 20, 2008 by a Male patient taking Genotonorm (View Usage) (Dosage: ) was diagnosed with growth hormone deficiency and. Location: FRANCE , weighting 63.93 lb, Patient experienced the following unwanted or unexpected effects: medulloblastoma recurrent.

5751265-5 | Colon Cancer Metastatic
on Mar 21, 2008 Male patient from FRANCE , weighting 227.1 lb, was diagnosed with hypopituitarism and was treated with Genotonorm (View Usage). Patient had the following side effects: colon cancer metastatic. Genotonorm dosage: Daily Dose:.3mg-freq:daily. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), TOCO (View Toco Review and Toco Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), URSOLVAN 200 (View Ursolvan-200 Review and Ursolvan-200 Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), EZETROL (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

5745548-2 | Pituitary Tumour Benign
on May 13, 2008 Female patient from FRANCE , weighting 152.1 lb, was diagnosed with hypopituitarism and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: pituitary tumour benign. Genotonorm dosage: Daily Dose:.3mg-freq:daily. During the same period patient was treated with DESMOPRESSIN ACETATE (Daily Dose:.2mg-freq:daily) (View Desmopressin Acetate Review and Desmopressin Acetate Label ), VARNOLINE (Text:1 Tablet-freq:daily) (View Varnoline Review and Varnoline Label ). Patient was hospitalized.

5720460-3 | Deformity Thorax
Patient was taking Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: deformity thorax on Apr 17, 2008 from FRANCE Additional patient health information: Male patient , 17 years of age, was diagnosed with growth hormone deficiency and. Genotonorm dosage: .

5708570-8 | Malaise, Ventricular Hypertrophy
Adverse event was reported on Apr 10, 2008 by a Female patient taking Genotonorm (View Usage) (Dosage: ) . Location: FRANCE , child 7 years of age, Patient had the following side effects: malaise, ventricular hypertrophy.

5683275-0 | Gastric Cancer
on Mar 19, 2008 Male patient from BELGIUM , weighting 33.07 lb, was diagnosed with small for dates baby and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: gastric cancer. Genotonorm dosage: . Patient was hospitalized.

5651699-3 | Epilepsy, Neoplasm Recurrence
on Feb 22, 2008 Male patient from FRANCE , weighting 18.74 lb, was diagnosed with hypopituitarism and was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?), neoplasm recurrence. Genotonorm dosage: Daily Dose:.3mg-freq:daily. During the same period patient was treated with CARBAMAZEPINE (Text:1.5 Tab) (View Carbamazepine Review and Carbamazepine Label ), DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), FLUTICASONE PROPIONATE (Text:50 X 2 /d) (View Fluticasone Propionate Review and Fluticasone Propionate Label ). Patient was hospitalized.

5628881-4 | Osteochondrosis
Patient was taking Genotonorm (View Usage). Patient had the following side effects: osteochondrosis on Feb 08, 2008 from FRANCE Additional patient health information: Male patient , child 3 years of age, was diagnosed with growth hormone deficiency and. Genotonorm dosage: .

5625000-5 | Pancreatitis Haemorrhagic
Adverse event was reported on Feb 01, 2008 by a Female patient taking Genotonorm (View Usage) (Dosage: Daily Dose:1.2mg-freq:daily) was diagnosed with hypopituitarism, thyroid disorder and. Location: FRANCE , weighting 213.8 lb, After Genotonorm was administered, patient had the following side effects: pancreatitis haemorrhagic. During the same period patient was treated with LEVOTHYROXINE SODIUM (Daily Dose:125mcg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PREVISCAN (View Previscan Review and Previscan Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DESMOPRESSIN (View Desmopressin Review and Desmopressin Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

5607124-1 | Cellulitis
on Jan 17, 2008 Male patient from FRANCE , child 12 years of age, was diagnosed with growth retardation and was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?). Genotonorm dosage: . Patient was hospitalized.

5596412-3 | Pancreatitis Haemorrhagic
on Jan 09, 2008 Female patient from FRANCE , weighting 213.8 lb, was diagnosed with hypopituitarism and was treated with Genotonorm (View Usage). Patient had the following side effects: pancreatitis haemorrhagic. Genotonorm dosage: Daily Dose:1.2mg-freq:daily. During the same period patient was treated with LEVOTHYROXINE SODIUM (Daily Dose:125mcg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PREVISCAN (View Previscan Review and Previscan Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DESMOPRESSIN (View Desmopressin Review and Desmopressin Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

5590692-6 | Eyelid Oedema, Headache, Hyperthermia
Patient was taking Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: eyelid oedema, headache (What is headache?), hyperthermia on Jan 08, 2008 from SPAIN Additional patient health information: Male patient , child 5 years of age, was diagnosed with foetal growth retardation and. Genotonorm dosage: Daily Dose:.4mg-freq:every Day.

5558814-0 | Gastric Cancer
Adverse event was reported on Dec 07, 2007 by a Male patient taking Genotonorm (View Usage) (Dosage: ) was diagnosed with hypopituitarism and. Location: BELGIUM , 74 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: gastric cancer. During the same period patient was treated with HYDROCORTISON (Daily Dose:30mg) (View Hydrocortison Review and Hydrocortison Label ), LEVOTHYROXINE SODIUM (Daily Dose:100mg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TESTOSTERONE (Daily Dose:250mg) (View Testosterone Review and Testosterone Label ).

5558813-9 | Breast Cancer
on Dec 07, 2007 Female patient from BELGIUM , 66 years of age, weighting 145.5 lb, was diagnosed with hypopituitarism and was treated with Genotonorm (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Genotonorm dosage: Daily Dose:.4mg-freq:daily. During the same period patient was treated with CABERGOLINE (View Cabergoline Review and Cabergoline Label ).

5487444-4 | Arthralgia, Gait Disturbance, Synovitis
on Oct 04, 2007 Male patient from FRANCE , weighting 43.43 lb, was diagnosed with body height below normal and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: arthralgia, gait disturbance, synovitis. Genotonorm dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ETANERCEPT (View Etanercept Review and Etanercept Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), APRANAX (View Apranax Review and Apranax Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5480790-X | Arthralgia, Gait Disturbance
Patient was taking Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, gait disturbance on Mar 12, 2007 from FRANCE Additional patient health information: Male patient , weighting 43.43 lb, was diagnosed with body height below normal and. Genotonorm dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ETANERCEPT (View Etanercept Review and Etanercept Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), APRANAX (View Apranax Review and Apranax Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5442315-4 | Depression, Obsessive-compulsive Disorder
Adverse event was reported on Jul 10, 2007 by a Male patient taking Genotonorm (View Usage) (Dosage: Daily Dose:1.4mg-freq:frequency: Daily) was diagnosed with growth hormone deficiency and. Location: FRANCE , weighting 66.14 lb, Patient had the following side effects: depression (What is depression?), obsessive-compulsive disorder (What is obsessive-compulsive disorder?).

5411604-1 | Depression, Obsessive-compulsive Disorder
on Aug 03, 2007 Male patient from FRANCE , weighting 66.14 lb, was diagnosed with growth hormone deficiency and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: depression (What is depression?), obsessive-compulsive disorder (What is obsessive-compulsive disorder?). Genotonorm dosage: Daily Dose:1.4mg-freq:frequency: Daily.

5390587-7 | Depression, Obsessive-compulsive Disorder
on Jul 06, 2007 Male patient from FRANCE , 13 years of age, was diagnosed with growth hormone deficiency and was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), obsessive-compulsive disorder (What is obsessive-compulsive disorder?). Genotonorm dosage: .

5388547-5 | Adrenocortical Insufficiency Acute
Patient was taking Genotonorm (View Usage). Patient had the following side effects: adrenocortical insufficiency acute on Jul 05, 2007 from FRANCE Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with hypopituitarism, hypothyroidism, adrenal insufficiency, cardiovascular event prophylaxis, hypertension, dyslipidaemia and. Genotonorm dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (Daily Dose:100) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), PLAVIX (View Plavix Review and Plavix Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ).

5386804-X | Colon Cancer Metastatic
Adverse event was reported on Jul 03, 2007 by a Male patient taking Genotonorm (View Usage) (Dosage: Daily Dose:.3mg-freq:daily) was diagnosed with hypopituitarism and. Location: FRANCE , weighting 227.1 lb, After Genotonorm was administered, patient had the following side effects: colon cancer metastatic. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), TOCO (View Toco Review and Toco Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), URSOLVAN 200 (View Ursolvan-200 Review and Ursolvan-200 Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), EZETROL (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

5381080-6 | Adrenocortical Insufficiency Acute
on Jun 28, 2007 Female patient from FRANCE , weighting 163.1 lb, was diagnosed with hypopituitarism, hypothyroidism, adrenal insufficiency, cardiovascular event prophylaxis, hypertension, dyslipidaemia and was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: adrenocortical insufficiency acute. Genotonorm dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (Daily Dose:100) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), PLAVIX (View Plavix Review and Plavix Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ).

5377598-2 | Colon Cancer Metastatic
on Jun 25, 2007 Male patient from FRANCE , weighting 227.1 lb, was diagnosed with hypopituitarism and was treated with Genotonorm (View Usage). Patient had the following side effects: colon cancer metastatic. Genotonorm dosage: Daily Dose:.3mg-freq:daily. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), TOCO (View Toco Review and Toco Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), URSOLVAN 200 (View Ursolvan-200 Review and Ursolvan-200 Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), EZETROL (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

5360980-7 | Systemic Lupus Erythematosus
Patient was taking Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: systemic lupus erythematosus on Jun 06, 2007 from SPAIN Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with growth hormone deficiency and. Genotonorm dosage: Daily Dose:.2mg. During the same period patient was treated with TRIAGYNON (View Triagynon Review and Triagynon Label ). Patient was hospitalized and became disabled.

5351197-0 | Systemic Lupus Erythematosus
Adverse event was reported on May 29, 2007 by a Female patient taking Genotonorm (View Usage) (Dosage: Daily Dose:.4mg) was diagnosed with growth hormone deficiency and. Location: SPAIN , weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: systemic lupus erythematosus. Patient was hospitalized and became disabled.

5348421-7 | Arthralgia, Intermittent Claudication
on May 25, 2007 Male patient from FRANCE , weighting 43.43 lb, was diagnosed with body height below normal and was treated with Genotonorm (View Usage). Patient had the following side effects: arthralgia, intermittent claudication. Genotonorm dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ETANERCEPT (View Etanercept Review and Etanercept Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), APRANAX (View Apranax Review and Apranax Label ), METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ). Patient was hospitalized.

5337385-8 | Osteoarthritis
on May 21, 2007 Male patient from FRANCE , 25 years of age, weighting 154.3 lb, was diagnosed with growth retardation and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: osteoarthritis (What is osteoarthritis?). Genotonorm dosage: .

5324383-3 | Osteochondrosis
Patient was taking Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: osteochondrosis on May 07, 2007 from CHILE Additional patient health information: Female patient , 13 years of age, . Genotonorm dosage: .

5317275-7 | Arthralgia, Arthritis
Adverse event was reported on Apr 22, 2007 by a Female patient taking Genotonorm (View Usage) (Dosage: ) . Location: CHILE , 13 years of age, Patient had the following side effects: arthralgia, arthritis (What is arthritis?).

5299808-2 | Hepatitis
on Apr 06, 2007 Female patient from FRANCE , 18 years of age, was diagnosed with turner's syndrome and was treated with Genotonorm (View Usage). After Genotonorm was administered, patient had the following side effects: hepatitis (What is hepatitis?). Genotonorm dosage: Daily Dose:2mg.

5280670-9 | Headache, Joint Contracture, Neck Pain, Sinusitis
on Mar 19, 2007 Female patient from FRANCE , child 12 years of age, was diagnosed with growth hormone deficiency and was treated with Genotonorm (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), joint contracture, neck pain, sinusitis (What is sinusitis?). Genotonorm dosage: Daily Dose:1mg. Patient was hospitalized and became disabled.

5271565-5 | Intermittent Claudication
Patient was taking Genotonorm (View Usage). Patient had the following side effects: intermittent claudication on Mar 12, 2007 from FRANCE Additional patient health information: Male patient , weighting 43.43 lb, was diagnosed with body height below normal and. Genotonorm dosage: Text:1 Mg-freq:every Day. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ETANERCEPT (View Etanercept Review and Etanercept Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), APRANAX (View Apranax Review and Apranax Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CALCIDOSE (View Calcidose Review and Calcidose Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ). Patient was hospitalized.